Response to Costantini et al. “Comments on Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer”

Jong Mu Sun

doi:10.1016/j.jtho.2017.11.122

Response to Costantini et al. “Comments on Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer”

Jong Mu Sun

Sungkyunkwan University

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	e56-e57
Journal	Journal of Thoracic Oncology
Volume	13
Issue number	4
DOIs	https://doi.org/10.1016/j.jtho.2017.11.122
State	Published - Apr 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jtho.2017.11.122

Cite this

@article{8877aeb1eed04968bdeb3f88621564a1,

title = "Response to Costantini et al. “Comments on Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer”",

author = "Sun, \{Jong Mu\}",

year = "2018",

month = apr,

doi = "10.1016/j.jtho.2017.11.122",

language = "English",

volume = "13",

pages = "e56--e57",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Response to Costantini et al. “Comments on Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer”

AU - Sun, Jong Mu

PY - 2018/4

Y1 - 2018/4

UR - https://www.scopus.com/pages/publications/85044124636

U2 - 10.1016/j.jtho.2017.11.122

DO - 10.1016/j.jtho.2017.11.122

M3 - Letter

C2 - 29576292

AN - SCOPUS:85044124636

SN - 1556-0864

VL - 13

SP - e56-e57

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4

ER -

Response to Costantini et al. “Comments on Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer”

UN SDGs

Access to Document

Other files and links

Cite this